|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
8 June 2015 |
|
Main ID: |
NCT02307071 |
|
Date of registration:
|
01/12/2014 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Occipital Transcutaneous Stimulation in Chronic Migraine
OSCRO |
|
Scientific title:
|
Transcutaneous Suboccipital Neurostimulation for the Treatment of Chronic Migraine |
|
Date of first enrolment:
|
November 2014 |
|
Target sample size:
|
20 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT02307071 |
|
Study type:
|
Interventional |
|
Study design:
|
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
Phase:
|
Phase 4
|
|
|
Countries of recruitment
|
|
Belgium
| | | | | | | |
|
Contacts
|
|
Name:
|
Anna Cosseddu, MD |
|
Address:
|
|
|
Telephone:
|
+3242256925 |
|
Email:
|
cossedduanna@gmail.com |
|
Affiliation:
|
|
|
|
Name:
|
Anna Cosseddu, MD |
|
Address:
|
|
|
Telephone:
|
+3242256925 |
|
Email:
|
cossedduanna@gmail.com |
|
Affiliation:
|
|
|
|
Name:
|
Delphine Magis, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Liège |
|
|
Name:
|
Jean Schoenen, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Liège |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- diagnosis of chronic migraine (ICHD III beta 1.3) with or without medication overuse
Exclusion Criteria:
- other diseases
Age minimum:
18 Years
Age maximum:
65 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Chronic Migraine
|
|
Intervention(s)
|
|
Device: Cefaly Kit Arnold
|
|
Primary Outcome(s)
|
|
Monthly frequency of migraine days
[Time Frame: 2 months treatment]
|
|
Secondary Outcome(s)
|
|
Monthly frequency of total headache days
[Time Frame: 2 months]
|
|
Cumulative monthly headache hours
[Time Frame: 2 months]
|
|
Monthly acute drug intake
[Time Frame: 2 months]
|
|
Monthly frequency of headache days
[Time Frame: 2 months]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|